RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GLYC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

GlycoMimetics stock price took a fall of -5.66% on Thursday
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 27, 2024 Loss -5.66% PDF

The GlycoMimetics stock price fell by -5.66% on the last day (Thursday, 28th Mar 2024) from $3.18 to $3.00. During the last trading day the stock fluctuated 7.24% from a day low at $2.90 to a day high of $3.11. The price has risen in 6 of the last 10 days and is up by 14.94% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -26 thousand shares and in total, 648 thousand shares were bought and sold for approximately $1.94 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.76% during the next 3 months and, with a 90% probability hold a price between $2.40 and $3.20 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GLYC Signals & Forecast

The GlycoMimetics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.96 and $2.94. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -5.66%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for GlycoMimetics stock

GlycoMimetics finds support from accumulated volume at $2.93 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.210 between high and low, or 7.24%. For the last week, the stock has had daily average volatility of 7.76%.

Our recommended stop-loss: $2.82 (-5.84%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (GLYC) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect GlycoMimetics to open at $3.00, and during the day (based on 14 day Average True Range), to move between $2.76 and $3.24, which gives a possible trading interval of +/-$0.236 (+/-7.87%) up or down from last closing price. If GlycoMimetics takes out the full calculated possible swing range there will be an estimated 15.74% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.03 (1.00%) than the support at $2.93 (2.33%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is GlycoMimetics stock A Buy?

GlycoMimetics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.546 Hold/Accumulate Downgraded

Predicted Opening Price for GlycoMimetics of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$3.00 ( 0.111%) $3.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GLYC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.21 7.11 %
R2 3.13 4.44 %
R1 3.08 2.79 %
Current price: 3.00
Support S1 2.92 -2.56 %
S2 2.87 -4.21 %
S3 2.79 -6.89 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.20 6.67 %
R2 3.18 6.00 %
R1 3.03 1.00 %
Current price 3.00
Support S1 2.93 -2.33%
S2 2.87 -4.33%
S3 2.80 -6.67%

FAQ

What is the symbol for GlycoMimetics Stock and on which exchange is it traded?
The symbol for GlycoMimetics is GLYC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell GlycoMimetics Stock?
GlycoMimetics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy GlycoMimetics Stock?
GlycoMimetics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy GlycoMimetics Stock.

What's the current price of GlycoMimetics Stock?
As of the end of day on the 2024-03-28, the price of an GlycoMimetics (GLYC) share was $3.00.

What is the 52-week high and low for GlycoMimetics Stock?
The 52-week high for GlycoMimetics Stock is $3.53 and the 52-week low is $1.11.

What is the market capitalization of GlycoMimetics Stock?
As of the 2024-03-28, the market capitalization of GlycoMimetics is 204.771M.

When is the next earnings date for GlycoMimetics?
The upcoming earnings date for GlycoMimetics is May 01, 2024.
Click to get the best stock tips daily for free!

About GlycoMimetics

GlycoMimetics GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G... GLYC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT